69
Prince Pharmaceutical Co., Ltd.
6935.TWO · TWO
$28.10 -0.88% (-$0.25)
1M -9.57%
Market Cap $1.06B
P/E Ratio 11.01x
Div. Yield 1.76%
ROE 12.14%
Bulios Fair Price
$37.49
33.4% upside
Current Price
$28.1
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6935.TWO is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
95 /100
Cheap P/E 11.01x
EV/EBITDA 7.56x
P/S 1.00x
Growth
69 /100
Growing EPS growth 19.27%
Rev. growth 14.02%
FCF growth 0.28%
Profitability
46 /100
Moderate Gross margin 21.07%
Net margin 9.12%
Op. margin 10.50%
Quality
53 /100
Average ROIC 8.08%
ROE 12.14%
ROA 6.41%
Debt
84 /100
Low Debt/Equity 0.50x
Current ratio 1.81x
Int. coverage 11.93x
Stability
36 /100
Moderate Beta 0.61x
Rev. volatility 32.20%
EPS volatility 363.93%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6935.TWO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Da Li
Employees
216
Headquarters
Yúnlín